Cubist Systematic Strategies, LLC Neoleukin Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.5 - $0.72 $6,716 - $9,671	13,432 Added 149244.44%	13,441 $9,000
Q4 2022 Feb 14, 2023	SELL	$0.4 - $0.55 $2,441 - $3,357	-6,104 Reduced 99.85%	9 $0
Q3 2022 Nov 14, 2022	SELL	$0.69 - $1.33 $2,248 - $4,334	-3,259 Reduced 34.77%	6,113 $4,000
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.25 $22,924 - $56,065	-24,918 Reduced 72.67%	9,372 $10,000
Q1 2022 May 16, 2022	BUY	$1.72 - $5.23 $25,829 - $78,538	15,017 Added 77.92%	34,290 $64,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $71,521 - $119,202	15,381 Added 395.2%	19,273 $93,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $9,722 - $15,523	-1,607 Reduced 29.22%	3,892 $28,000
Q2 2021 Aug 16, 2021	BUY	$9.23 - $13.12 $40,602 - $57,714	4,399 Added 399.91%	5,499 $51,000
Q1 2021 May 17, 2021	BUY	$11.26 - $15.78 $5,765 - $8,079	512 Added 87.07%	1,100 $14,000
Q4 2020 Feb 16, 2021	BUY	$10.17 - $14.56 $5,888 - $8,430	579 Added 6433.33%	588 $8,000
Q3 2020 Nov 16, 2020	SELL	$9.68 - $17.01 $128,966 - $226,624	-13,323 Reduced 99.93%	9 $0
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $35,949 - $61,601	3,613 Added 37.17%	13,332 $221,000
Q1 2020 May 15, 2020	SELL	$6.12 - $13.64 $73,537 - $163,898	-12,016 Reduced 55.28%	9,719 $111,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $12.72 $57,597 - $276,469	21,735 New	21,735 $268,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.